MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Down 31.3% in February

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the recipient of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 293,300 shares, a decrease of 31.3% from the February 13th total of 426,700 shares. Based on an average daily volume of 142,600 shares, the days-to-cover ratio is presently 2.1 days.

MediPharm Labs Stock Up 8.0 %

Shares of MEDIF opened at $0.06 on Tuesday. The stock has a 50 day moving average price of $0.05 and a 200 day moving average price of $0.05. MediPharm Labs has a 52-week low of $0.04 and a 52-week high of $0.07.

MediPharm Labs Company Profile

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.